Our unique offering of ChemPass AI is directed
Evogene’s wholly owned subsidiary, AgPlenus, brings years of experience, proven results, and collaborations with leading global companies in the development of ag-chemical products – enabling next-generation crop-protection solutions and delivering cutting-edge agricultural chemistry.
Built on this foundation, Evogene expands its solutions into pharma – where ChemPass AI has the potential to significantly increase the likelihood of discovering novel, potent, and commercially promising small-molecule therapeutics, advancing a new era of AI-driven pharmaceutical innovation.
